Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-24 @ 10:40 PM
NCT ID:
NCT02832635
Eligibility Criteria:
Inclusion Criteria:
* Primary lesions diagnosed by pathology or cytology
* Brain metastases confirmed by brain MRI or CT(\>3 brain metastases）
* Brain metastases beyond 5mm of hippocampus
* Male or female patients with age between 18 and 75 years old
* Karnofsky Performance Scores ≥ 60
* Expected survival ≥ 6 months
* No previous brain surgery or brain radiotherapy
* Without dysfunction of heart, lung, liver, kidney and hematopoiesis
* The primary carcinoma is under control
Exclusion Criteria:
* MMSE score \<27
* Dysfunction of heart, lung, liver, kidney or hematopoiesis
* Severe neurological, mental or endocrine diseases
* History of alcohol or drug abuse within 3 months
* Visual or hearing dysfunction, low education level, or other reasons leading to not capable of taking the MMSE test
* Currently under treatment may effect patients' neurocognitive functions
* Patients participated in clinical trials of other drugs within last 3 months
* Other unsuitable reason
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02832635
Study Brief:
Protocol Section:
NCT02832635